From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

A Letter to AIM Regulation: Is SP Angel fit and proper to act as a Nomad (and should the FCA investigate it as well)

By Tom Winnifrith, The Sheriff of AIM | Thursday 23 August 2018


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Enough is enough. Yesterday John Meyer, a senior manager and large shareholder in SP Angel went onto Justin the Clown’s podcast to ramp corporate stocks such as Blue Jay Mining (JAY) without declaring an interest – his employer earns vast fees from Blue Jay as its Nomad and broker. But this is the least of SP Angel’s crimes and I wonder if its conduct over Blue Jay and MySquar (MYSQ) is, if not blatant market abuse, simply bringing the AIM Casino into disrepute. I have written to Marcus Stuttard, the head of AIM Regulation, demanding an immediate investigation into whether SP Angel should retain its Nomad license.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 23:11:25